Rx (Prescription Medicine)
USD $ 120.00
Adrib 10mg Injection 是一种关键药物，用于管理多种癌症。其活性成分多柔比星（Doxorubicin）是一种蒽环类抗生素，通过干扰癌细胞的生长并减缓其增殖起作用。多柔比星（Doxorubicin）通过静脉注射给药，是一种强效的化疗药物。它常用于治疗乳腺癌、肺癌、卵巢癌、膀胱癌、淋巴瘤及白血病等多种恶性肿瘤。具体的剂量和治疗时长取决于癌症的种类和阶段、患者的整体健康状况以及对疗法的反应。常见的不良反应可能包括恶心、呕吐、脱发、骨髓抑制（导致血细胞计数下降）以及心脏毒性。接受Adrib 10mg Injection治疗的患者需由医护专业人员进行密切监测。应储存在室温、避光的环境中，并因其细胞毒性特性需谨慎操作。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength | |
| Brand Name | |
| Molecule | |
| Strength | 10 Mg |
| Medicine Form | Injection |
| Pack Quantity | 1 Bottle |
| Packaging Type | Vial |
| Medicine Type | Generic |
| Country Of Origin | India |
| Rx Status | Rx (Prescription Medicine) |
其他品牌的 Doxorubicin 10 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
